StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Glaukos Corporation
NYSE:GKOS
Sector
Location
Market Cap
USD 5.93 B
Share Price
USD 103.81
Avg Daily Volume
959,166
Change (1 day)
-2.57%
Change (1 year)
-15.77%
Change (YTD)
-30.77%
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 36.05 M
Glaukos Corporation Depreciation And Amortization is USD 36.05 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -6.66% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
-
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 38.62 M, a 6.08% change year over year.
-
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 36.41 M, a 4.76% change year over year.
-
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 34.75 M, a 0.62% change year over year.
-
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 34.54 M, a 100.32% change year over year.
Competitors
Santen Pharmaceutical Co., Ltd.
USD 11.08
4536.T
-0.19
-1.66%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.45
300573.SZ
+0.08
1.14%
Ocular Therapeutix, Inc.
USD 11.03
OCUL
-0.05
-0.45%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%
Key Data
| Date | Depreciation And Amortization | Dividends Paid | Common Stock Issued | Common Stock Repurchased |
|---|
Competitors
Santen Pharmaceutical Co., Ltd.
USD 11.08
4536.T
-0.19
-1.66%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.45
300573.SZ
+0.08
1.14%
Ocular Therapeutix, Inc.
USD 11.03
OCUL
-0.05
-0.45%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%